AKT1 and cancer: Indeed, we observed the substantial decrease of half-life of Rad51 in GIST cells treated with CHX in presence of MK-2206, thereby suggesting about the rapid turnover of protein in AKT-inhibited cancer cells (Figure 8, upper and middle panels).